NCT06085833 - ARTIDIS Nanomechanical Generated Measurements for Early Breast Lesions | Biotech Hunter

Enrollment

2,706

Participants

Timeline

Start Date

November 2, 2023

Primary Completion Date

December 31, 2026

Study Completion Date

November 30, 2035

Conditions

Breast Cancer

Interventions

DIAGNOSTIC_TEST

Nanomechanical Phenotype Test

The ARTIDIS ART-1 device is an in-vitro diagnostic device based on Atomic Force Microscope (AFM) technology. The ART-1 device uses a probe to measure the nanomechanical phenotype of tissue components. ARTIDIS nanomechanical phenotype measurements are performed on fresh tissue after it is collected via biopsy or resection.

Trial Locations (1)

77030

RECRUITING

Baylor College of Medicine, Houston

All Listed Sponsors

lead

ARTIDIS AG

INDUSTRY